Industry Attorney: FDA Quietly Announced It Will Not Implement DQSA

FDA is going against congressional intent and potentially running afoul of the law by quietly killing its earlier plans to implement portions of the Drug Quality and Security Act (DQSA), a drug industry attorney tells Inside Health Policy . The attorney explains that by putting a number of compounding rules on the inactive list of the most recent regulatory agenda, FDA's controversial interim policy that allows 503B outsourcing facilities to compound a number of ingredients indefinitely until FDA says otherwise,...